10,983
Total Claims
$1.5M
Drug Cost
1,436
Beneficiaries
$1,025
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-33%
Cost per patient vs peers
$1,025 vs $1,524 avg
+7%
Brand preference vs peers
14.7% vs 13.7% avg
Brand vs Generic
85% generic
Brand: 1,611 claims · $1.3M
Generic: 9,372 claims · $204K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 624 | $593K |
| Rivaroxaban | 312 | $282K |
| Sacubitril/Valsartan | 216 | $199K |
| Evolocumab | 55 | $41K |
| Dapagliflozin Propanediol | 27 | $27K |
| Ticagrelor | 30 | $25K |
| Empagliflozin | 11 | $18K |
| Icosapent Ethyl | 33 | $15K |
| Clopidogrel Bisulfate | 959 | $15K |
| Clonidine | 42 | $9,306 |
| Sotalol Hcl | 298 | $8,704 |
| Valsartan | 269 | $8,587 |
| Potassium Chloride | 296 | $8,490 |
| Ranolazine | 73 | $8,372 |
| Propafenone Hcl | 134 | $7,854 |
Prescribing Profile
87
Unique Drugs
$1.1M
Patient Profile
74
Avg Age
51%
Female
1.64
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data